BioCentury
ARTICLE | Company News

Management tracks: Tissue Regenix, Therapix

November 3, 2017 10:53 PM UTC

Regenerative medical device company Tissue Regenix Group plc (LSE:TRX) named Steve Couldwell CEO. A Tissue Regenix director since 2013, Couldwell was COO of global biosurgery at Sanofi (Euronext:SAN; NYSE:SNY).

Cannabinoid company Therapix Biosciences Ltd. (Tel Aviv:TRPX; NASDAQ:TRPX) named its chairman, Ascher Shmulewitz, interim CEO. Elran Haber stepped down as CEO in May...